Will neo-adjuvant immunotherapy become a new paradigm in the treatment of lung cancer patients

Nowadays neoadjuvant immunotherapy is one of the main research areas in oncology. This interest is supported by the success of check-point inhibitors in treatment of advanced and metastatic lung cancer. The postulate that neoadjuvant immunotherapy achieves tumor devitalization before surgery is conf...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: K. K. Laktionov, V. V. Breder, D. I. Yudin, K. A. Sarantseva, L. V. Laktionova, M. S. Ardzinba, E. V. Reutova, A. V. Egorova
Formato: Artigo
Idioma:Russo
Publicado em: Remedium Group LLC 2019-12-01
Colecção:Медицинский совет
Assuntos:
neoadjuvant immunotherapy
non-small cell lung cancer
checkpoint inhibitors
Acesso em linha:https://www.med-sovet.pro/jour/article/view/5047
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados